RSS   Newsletter   Contact   Advertise with us
Post Online Media

Agios Pharmaceuticals appoints CFO

Andrew HirschAgios Pharmaceuticals, a pharmaceutical company, announced that Andrew Hirsch is joining the company as chief financial officer from September 19, 2016.

Mr. Hirsch has more than 20 years of experience in a range of strategic and operating roles in the biotechnology sector, most recently having served as president and chief executive officer of BIND Therapeutics.

READ MORE Agios Pharmaceuticals: David Schenkein CEO, Duncan Higgons COO

Prior to being named president and chief executive officer at BIND, he held several other leadership positions at the company, including chief operating officer and chief financial officer.

Prior to joining BIND, Mr. Hirsch was chief financial officer at Avila Therapeutics until its acquisition by Celgene and held roles of increasing responsibility during his nearly 10-year tenure at Biogen, including vice president of Corporate Strategy and M&A and program executive for the Tecfidera development team.

Mr. Hirsch holds a Masters of Business Administration from the Tuck School at Dartmouth College and a Bachelor of Arts in Economics from the University of Pennsylvania.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy